Navigation Links
The Lancet Publication Of LAPLACE-TIMI 57 And MENDEL Studies Showed AMG 145 Significantly Reduced LDL Cholesterol
Date:11/6/2012

didates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent ap
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Results For Phase 2b Trial Of Unique Investigational Cell-Based Therapy In Venous Leg Ulcers Published In The Lancet
2. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
3. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
4. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
5. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
6. Publication of PrEP Trial Data Provides Clear Evidence that PrEP Works for Men and Women
7. Amsterdam Molecular Therapeutics (AMT) Holding N.V. (in liquidation) Announces Publication of its Accounts for 2011 and Notice of Annual General Meeting
8. ESTEVE Announces Publication of Key Preclinical Data for a Novel Oral, First-in-class New Chemical Entity (NCE) Sigma-1 Receptor Antagonist (E-52862), that has Completed Phase I and Initiated its Phase II Clinical Trial Program
9. Avanir Pharmaceuticals Announces Publication Of PBA Burden Of Illness Study
10. International Spine Products Manufacturer Featured in Upcoming US Business Executive Publication - www.gsmedicalusa.com
11. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)...   Rio Grande Valley Health Information Exchange (RGV ... Health Science Center at Houston (UTHealth)  School of Public ... selected Wellcentive,s suite of population health management solutions and ... to partner with hospitals and clinics in the region ... uninsured patient populations, initially focusing on the care of ...
(Date:11/18/2014)... 18, 2014 Profile Solutions, Inc. (OTC ... access control and security systems is pleased to ... Rush Alliance and will provide the companies proprietary ... the Cannabis Industry. The Company will also provide ... dispensaries, retailers and grow operations. Profile ...
(Date:11/18/2014)... Medical Services Holdings Limited ("Concord Medical" or the ... of specialty cancer hospitals and the largest network ... today announced its unaudited consolidated financial results for ... . Third Quarter 2014 Highlights ... revenues generated from the network business and hospital ...
Breaking Medicine Technology:Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 2Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 3Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 4Profile Solutions, Inc Joins the Green Rush Alliance 2Profile Solutions, Inc Joins the Green Rush Alliance 3Concord Medical Reports Third Quarter 2014 Financial Results 2Concord Medical Reports Third Quarter 2014 Financial Results 3Concord Medical Reports Third Quarter 2014 Financial Results 4Concord Medical Reports Third Quarter 2014 Financial Results 5Concord Medical Reports Third Quarter 2014 Financial Results 6Concord Medical Reports Third Quarter 2014 Financial Results 7Concord Medical Reports Third Quarter 2014 Financial Results 8Concord Medical Reports Third Quarter 2014 Financial Results 9Concord Medical Reports Third Quarter 2014 Financial Results 10Concord Medical Reports Third Quarter 2014 Financial Results 11Concord Medical Reports Third Quarter 2014 Financial Results 12Concord Medical Reports Third Quarter 2014 Financial Results 13Concord Medical Reports Third Quarter 2014 Financial Results 14Concord Medical Reports Third Quarter 2014 Financial Results 15Concord Medical Reports Third Quarter 2014 Financial Results 16Concord Medical Reports Third Quarter 2014 Financial Results 17Concord Medical Reports Third Quarter 2014 Financial Results 18
... AMGN ) reported revenue unchanged for the third ... the third quarter of 2009. Adjusted net income ... of 2010 compared to $1,518 million for the third quarter ... by unusually low research and development (R&D) costs and favorable ...
... The National Community Pharmacists Association (NCPA) is partnering with ... of independent community pharmacies, an agreement announced during NCPA,s ... be able to more easily apply for the large ... traded chain pharmacies (CVS Caremark, Walgreens, etc.), which have ...
Cached Medicine Technology:Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 2Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 3Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 4Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 5Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 6Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 7Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 8Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 9Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 10Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 11Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 12Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 13Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 14Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year 15NCPA Announces Partnership with Live Oak Bank to Help Finance Independent Community Pharmacy Purchases 2NCPA Announces Partnership with Live Oak Bank to Help Finance Independent Community Pharmacy Purchases 3
(Date:11/21/2014)... Launched today on the iTunes App Store, ... care coordination tool designed to make tracking and sharing ... for family members and caregivers (e.g. physicians home care ... caregiver or home health aide providing care for a ... records, goals, schedules, and even final plans in one ...
(Date:11/21/2014)... November 21, 2014 TruDenta, the creator ... headaches and other jaw-related symptoms, has reported a ... from chronic head pain, neck pain, TMJ (temporomandibular joint) ... year we have seen a 52% increase in the ... of over 300 doctors and their teams in 47 ...
(Date:11/21/2014)... Los Angeles, CA (PRWEB) November 21, 2014 ... coding reference for the dental practice. It includes everything ... pages . , Procedure Coding with CDT , CDT ... services provided from January 1, 2014 - December 31, ... to report procedures and services on dental claims. There ...
(Date:11/21/2014)... TopConsumerReviews.com recently awarded their highest ... in the relief of depression symptoms. ... sadness and depression each year and are unable ... prescription drugs can produce worse side effects than ... and require regular follow-up visits with a doctor. ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 According to ... issued on June 11th, 2014, the inflating system found ... when the airbag inflates. The force of inflation may ... and the metal shards may pierce the airbag’s fabric ... cabin. , According to a Bloomberg Business Week ...
Breaking Medicine News(10 mins):Health News:Comprehensive Senior Care Application Launched on Apple App Store 2Health News:National Rise In Patients Seeking Headache Relief 2Health News:PMIC Announces CDT PLUS! 2015, the Ultimate Coding Reference for Dentists and Oral Surgeons 2Health News:Depression Relief Product Receives Top 5-Star Rating from TopConsumerReviews.com 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3
... have, for the first time, taken adult stem cells and ... human jaw.They say the groundbreaking work may one day //lead ... suffer from temporomandibular disorders. ,The study started with ... these cells can be coaxed to become any other type ...
... the last half century, and officials at the ... be diagnosed with it this year.,The study, which analyzed ... ages of 30 and 50,// found what the researchers ... tanning can be dangerous to healthy skin. ,Melanoma ...
... and observational studies previously conducted in elderly populations ... were performed before intracoronary stents and use of ... Dr. Hanoch Hod, of Chaim Sheba Medical //Center ... consecutive patients aged 70 or older treated for ...
... hormone may help patients in treating a rare disorder ... metabolic abnormalities.The study's author found that the results of ... role of leptin in common metabolic conditions such as ... her colleagues found that a lab-engineered version of leptin, ...
... control to limit women's periods ,Seasonale, a new drug ... reduce the number of women's periods to four a year ... pills, but for longer spans of time.// ,Seasonale ... ,"For women who desire prevention of pregnancy and are comfortable ...
... milk chocolate, which is most commonly used in candy ... They found the same discouraging result among patients who ... suggest that milk and other dairy products somehow discourage ... chocolate. Only subjects who ate dark chocolate showed a ...
Cached Medicine News:Health News:Solarium use is associated with an increased risk of skin cancer 2Health News:Angioplasty plus stenting better than thrombolysis for elderly patients with AMI, 2Health News:Obesity Hormone -' Leptin' may treat Metabolic Disorder 2Health News:New birth control to limit women's periods 2Health News:When it comes to health, all chocolates not the same. 2
The first instrumentation to automate and efficiently manage the slide labeling process. Proven technology automatically feeds, prints and collates slides sequentially. Extensive data customization, ...
... ISI offers instrument cleaning brushes ... diameters and composition. The long, ... cannulas and tubing. The smallest ... micros. The brass and stainless ...
... wall-mounted organizer with a complete set of micro ... The Micro Nest makes it easier for technicians ... task. These small instrument cleaning brushes from ISI ... as cannulas. ISI Micro Brushes are available in ...
... Instra-Glide Soak is the non-silicone ... instruments by allowing parts to ... , ,Instra-Glide Soak is water-soluble ... without getting sticky or gummy. ...
Medicine Products: